Ranolazine improves myocardial perfusion in patients with coronary artery disease

被引：0
|
作者：
Venkataraman, R. [1 ]
Belardinelli, L. [2 ]
Blackburn, B. [2 ]
Heo, J. [1 ]
Collins, M. [1 ]
Iskandrian, A. E. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] CV Therapeut, Palo Alto, CA USA
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2009年 / 11卷 / 0B期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
64
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [41] PATTERNS OF DISTURBED MYOCARDIAL PERFUSION IN PATIENTS WITH CORONARY-ARTERY DISEASE - REGIONAL MYOCARDIAL PERFUSION IN ANGINA-PECTORIS
    SELWYN, AP
    FORSE, G
    FOX, K
    JONATHAN, A
    STEINER, R
    CIRCULATION, 1981, 64 (01) : 83 - 90
  • [42] Association between risk factors for coronary artery disease and coronary disease in patients undergoing myocardial perfusion scintigraphy
    Duarte, Paulo Schiavom
    Mastrocolla, Luiz Eduardo
    Alonso, Gilberto
    Lima, Eduardo Vilaca
    Smanio, Paola Emanuela
    Conde de Oliveira, Marco Antonio
    Fernandes Martins, Luiz Roberto
    Rodrigues Pereira, Julio Cesar
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2007, 88 (03) : 304 - 313
  • [43] Angina Relief by Ranolazine Identifies False-Negative SPECT Myocardial Perfusion Scans in Patients with Coronary Disease Demonstrated by Coronary Angiography
    Murray, Gary L.
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2014, 23 (03) : 165 - 170
  • [44] Tibolone, a selective estrogen receptor modulator, improves myocardial perfusion in postmenopausal women with coronary artery disease
    Campisi, R
    Camilletti, J
    Erriest, J
    Mele, A
    Pedroni, P
    Dopta, G
    Guiglioni, A
    CIRCULATION, 2004, 110 (17) : 657 - 657
  • [45] The effects of ranolazine on paroxysmal atrial fibrillation in patients with coronary artery disease
    Leftheriotis, D.
    Flevari, P.
    Theodorakis, G.
    Rigopoulos, A.
    Giannakakis, G.
    Simitsis, P.
    Aidonidis, I.
    Rizos, I.
    Anastasiou-Nana, M.
    EUROPEAN HEART JOURNAL, 2013, 34 : 749 - 750
  • [46] Coronary artery disease: a dam in the river for ranolazine
    Head, Stuart J.
    Kappetein, A. Pieter
    LANCET, 2016, 387 (10014): : 100 - 102
  • [47] Effect of Ranolazine on Left Ventricular Dyssynchrony in Patients With Coronary Artery Disease
    Venkataraman, Rajesh
    Chen, Ji
    Garcia, Ernest V.
    Belardinelli, Luiz
    Hage, Fadi G.
    Heo, Jaekyeong
    Iskandrian, Ami E.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (10): : 1440 - 1445
  • [48] Effects of Ranolazine on Ischemic Threshold, Coronary Sinus Blood Flow, and Myocardial Metabolism in Coronary Artery Disease
    Jens Peder Bagger
    Hans Erik Bøtker
    Anne Thomassen
    Torsten Toftegaard Nielsen
    Cardiovascular Drugs and Therapy, 1997, 11 : 479 - 484
  • [49] Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
    Tanja Kero
    Antti Saraste
    Bo Lagerqvist
    Jens Sörensen
    Essi Pikkarainen
    Mark Lubberink
    Juhani Knuuti
    Journal of Nuclear Cardiology, 2022, 29 : 24 - 36
  • [50] Quantitative myocardial perfusion assessment with magnetic resonance Imaging in patients with coronary artery disease
    Gramovich, VV
    Sinitsyn, VE
    Gordin, MP
    Stukalova, OV
    Samko, AN
    Ustyuzhanin, DV
    Ternovoy, SK
    KARDIOLOGIYA, 2004, 44 (08) : 4 - 12
12345